Pharmacy Grand Rounds Episode 8: Brexanolone: A New Hope? Updates on the Management of Postpartum Depression
Pharmacy Grand Rounds Podcast
In today’s podcast, Dr. Mikaela Hofer, PharmD, (@mikaelamhofer) discusses pathophysiology and treatment options for postpartum depression. With a prevalence ranging from ~6 – 13% per delivery, postpartum depression is relatively common...yet pharmacologic treatments options are sparse.
After a review of potential treatment barriers, Dr. Hofer will focus on new treatment targets for postpartum depression, including neurotransmitters and neurosteroids, as well as sharing insight on the potential role of brexanalone for this patient population.
- Identify risk factors associated with postpartum depression
- Review current options for treatment of postpartum depression
- Describe the potential place in therapy for brexanolone in treating postpartum depression
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
All travel and lodging expenses are the sole responsibility of the individual registrant.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 0.50 ACPE Knowledge -based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
2020 ACPE UAN Number: JA0000238-0000-20-060-H01-P
2021 ACPE UAN Number: JA0000238-0000-21-034-H01-P
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. Approval is valid until 09/02/2023. This activity is designated for 0.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
- 0.50 AAPA Category 1
- 0.50 ACPE
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Attendance